An Act to direct the Board of Medicine to convene a work group to create educational materials for patients considering breast implants.
HB573 directs the Virginia Board of Medicine to convene a work group to develop educational materials for patients considering breast implants. The work group must include plastic surgeons, primary care providers, oncologists, nurse practitioners, physician assistants, and hospitals, and it must produce both electronic and physical materials that promote best practices and inform patients about breast implant risks.
The required materials must cover several specific topics: possible complications from breast implants, breast implant-associated anaplastic large cell lymphoma, increased risk of certain autoimmune and connective tissue diseases, the option of aesthetic flat closure as an alternative, and other systemic symptoms associated with implants. The Board must complete and distribute the materials to its licensees by January 1, 2027.
The bill does not directly regulate the use of breast implants or create new licensing requirements; instead, it adds an educational and informational duty for the Board of Medicine. Its practical effect is to standardize patient-facing counseling resources across Virginia medical providers and to ensure that licensees receive state-developed materials reflecting current concerns about implant safety and alternatives. The bill may affect plastic surgery practices, primary care, oncology, and other providers who counsel patients on breast reconstruction or cosmetic breast procedures.
The available record shows no committee transcript or vote data, so there is no documented floor or committee debate to gauge support or opposition. Based on the enacted text, the bill appears to reflect a patient-safety and informed-consent approach, emphasizing disclosure of risks and alternatives rather than restricting access to breast implants.
No specific points of contention are documented in the provided materials. Potential areas of disagreement, based on the bill’s subject matter, could include the scope of risk information to be included, whether the materials might discourage implant use, and how prominently alternatives such as aesthetic flat closure should be presented. However, the record provided does not identify any legislators, stakeholders, or medical groups taking formal positions.